tiprankstipranks
Trending News
More News >
New Providence Acquisition Corp. III Class A (NPAC)
NASDAQ:NPAC
US Market
Advertisement

New Providence Acquisition Corp. III Class A (NPAC) Similar Stocks

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
New Providence Acquisition Corp. III Class A
$10.26
$393.89M
Bayview Acquisition Corp Class A
$11.41
$39.26M
93.75
6.94%
Roma Green Finance Limited
$2.85
$169.76M
-10.32
182.18%
FibroBiologics, Inc.
$0.33
$16.83M
-0.68
-89.94%
2 Buy
0 Hold
0 Sell
Moderate Buy
Alto Neuroscience, Inc.
$11.23
$304.07M
-4.68
199.47%
6 Buy
0 Hold
0 Sell
Strong Buy
Telomir Pharmaceuticals, Inc.
$1.41
$45.52M
-2.60
-66.59%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NPAC
New Providence Acquisition Corp. III Class A
10.26
-0.09
-0.87%
BAYA
Bayview Acquisition Corp Class A
11.32
0.72
6.79%
ROMA
Roma Green Finance Limited
2.85
1.84
182.18%
FBLG
FibroBiologics, Inc.
0.33
-2.92
-89.85%
ANRO
Alto Neuroscience, Inc.
11.23
7.48
199.47%
TELO
Telomir Pharmaceuticals, Inc.
1.41
-2.81
-66.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis